Connor, Clark & Lunn Investment Management Ltd. - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$43,000
-75.8%
13,700
-76.3%
0.00%
-100.0%
Q2 2016$178,000
-57.6%
57,767
-50.2%
0.00%
-66.7%
Q1 2016$420,000
-28.3%
115,990
-8.1%
0.00%
-40.0%
Q4 2015$586,000
-20.8%
126,190
+3.8%
0.01%
-16.7%
Q3 2015$740,000
-42.8%
121,590
-19.0%
0.01%
-50.0%
Q2 2015$1,294,000
+137.4%
150,100
+23.1%
0.01%
+140.0%
Q1 2015$545,000121,9000.01%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,900,000$16,378,0003.36%
Hilltop Park Associates LLC 120,000$1,034,0002.05%
Abingworth LLP 437,994$3,767,0001.71%
Sio Capital Management, LLC 238,158$2,053,0001.01%
Rhenman & Partners Asset Management AB 619,600$5,341,0000.64%
Broadfin Capital, LLC 1,370,457$11,813,0000.64%
Perceptive Advisors 1,202,156$10,363,0000.62%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 931,257$8,027,0000.60%
WEXFORD CAPITAL LP 177,500$1,530,0000.41%
Rock Springs Capital Management LP 470,000$4,051,0000.30%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders